{"retracted":false,"update":{"timestamp":1427846400000,"doi":"10.1016/j.bcp.2015.02.008","type":"err"},"doi":"10.1016/j.bcp.2014.03.015","journal":"Biochemical Pharmacology","publisher":"Elsevier BV","title":"Corrigendum to “A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats” [Biochem. Pharmacol. 89 (4) (2014) 536–544]"}
